Philip O. Buck

3.5k total citations · 1 hit paper
74 papers, 2.4k citations indexed

About

Philip O. Buck is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Philip O. Buck has authored 74 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 18 papers in Health and 13 papers in Infectious Diseases. Recurrent topics in Philip O. Buck's work include Vaccine Coverage and Hesitancy (15 papers), Sexual Assault and Victimization Studies (12 papers) and Influenza Virus Research Studies (11 papers). Philip O. Buck is often cited by papers focused on Vaccine Coverage and Hesitancy (15 papers), Sexual Assault and Victimization Studies (12 papers) and Influenza Virus Research Studies (11 papers). Philip O. Buck collaborates with scholars based in United States, Belgium and United Kingdom. Philip O. Buck's co-authors include Antonia Abbey, Tina Zawacki, Pam McAuslan, Christopher Saenz, A. Monique Clinton‐Sherrod, Michele R. Parkhill, Brandon J. Patterson, Lenwood W. Hayman, Carla Talarico and Paul A. Toro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Philip O. Buck

70 papers receiving 2.2k citations

Hit Papers

A systematic literature review of the global seroprevalen... 2022 2026 2023 2024 2022 25 50 75 100

Peers

Philip O. Buck
Nimesh Patel United States
Jennifer Cole United States
Anjani Chandra United States
Mary B. Short United States
Lee Warner United States
Heather B. Clayton United States
J. Michael Underwood United States
James C. Campbell United States
Patricia S. Coffey United States
Nimesh Patel United States
Philip O. Buck
Citations per year, relative to Philip O. Buck Philip O. Buck (= 1×) peers Nimesh Patel

Countries citing papers authored by Philip O. Buck

Since Specialization
Citations

This map shows the geographic impact of Philip O. Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip O. Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip O. Buck more than expected).

Fields of papers citing papers by Philip O. Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip O. Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip O. Buck. The network helps show where Philip O. Buck may publish in the future.

Co-authorship network of co-authors of Philip O. Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Philip O. Buck. A scholar is included among the top collaborators of Philip O. Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip O. Buck. Philip O. Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sauver, Jennifer L. St., Robert M. Jacobson, Susan A. Weston, et al.. (2025). Population-Based Incidence of Infectious Mononucleosis and Related Hospitalizations: 2010 Through 2021. Mayo Clinic Proceedings. 100(6). 982–992.
3.
Poulos, Christine, et al.. (2025). US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines. Journal of Medical Economics. 28(1). 279–290. 2 indexed citations
4.
Buck, Philip O., Ekkehard Beck, Noam Y. Kirson, et al.. (2024). New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement. Vaccines. 12(3). 234–234. 2 indexed citations
5.
Buck, Philip O., Renae L. Smith-Ray, Nicolas Van de Velde, et al.. (2023). Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic. Vaccine. 41(29). 4257–4266. 4 indexed citations
6.
Diaz‐Decaro, John, Evan R. Myers, Magdalena Kaczanowska, et al.. (2023). A systematic literature review of the economic and healthcare resource burden of cytomegalovirus. Current Medical Research and Opinion. 39(7). 973–986. 6 indexed citations
7.
Sweeney, Carolyn, et al.. (2022). Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices. Human Vaccines & Immunotherapeutics. 18(6). 2123180–2123180. 7 indexed citations
8.
Shiri, Tinevimbo, Carla Talarico, Angharad R. Morgan, et al.. (2022). The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program. Vaccines. 10(2). 140–140. 7 indexed citations
9.
Shiri, Tinevimbo, Marc Evans, Carla Talarico, et al.. (2021). Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example. Vaccines. 9(10). 1180–1180. 16 indexed citations
10.
Patterson, Brandon J., Philip O. Buck, Desmond Curran, et al.. (2021). Estimated Public Health Impact of the Recombinant Zoster Vaccine. SHILAP Revista de lepidopterología. 5(3). 596–604. 4 indexed citations
11.
Klein, Nicola P., Joan Bartlett, Bruce Fireman, et al.. (2017). Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine. Vaccine. 35(26). 3395–3400. 26 indexed citations
12.
Chen, Chi‐Chang, Catherine B. McGuiness, Girishanthy Krishnarajah, et al.. (2016). Estimated incidence of pertussis in people aged <50 years in the United States. Human Vaccines & Immunotherapeutics. 12(10). 2536–2545. 14 indexed citations
13.
Casciano, Julian, Jerry A. Krishnan, Mary Buatti Small, et al.. (2016). Burden of asthma with elevated blood eosinophil levels. BMC Pulmonary Medicine. 16(1). 100–100. 25 indexed citations
14.
Rendas‐Baum, Regina, Philip O. Buck, Michelle K. White, & Jane Castelli‐Haley. (2011). Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in parkinson's disease. Health and Quality of Life Outcomes. 9(1). 69–69. 2 indexed citations
15.
Silver, Dee E. & Philip O. Buck. (2011). Determining the Efficacy of Rasagiline in Reducing Bradykinesia Among Parkinson's Disease Patients: A Review. International Journal of Neuroscience. 121(9). 485–489. 2 indexed citations
16.
Testa, Maria, Mark T. Fillmore, Jeanette Norris, et al.. (2006). Understanding Alcohol Expectancy Effects: Revisiting the Placebo Condition. Alcoholism Clinical and Experimental Research. 30(2). 339–348. 111 indexed citations
17.
Zawacki, Tina, Jeanette Norris, William H. George, et al.. (2005). Explicating Alcohol???s Role in Acquaintance Sexual Assault: Complementary Perspectives and Convergent Findings. Alcoholism Clinical and Experimental Research. 29(2). 263–269. 10 indexed citations
18.
Abbey, Antonia, Tina Zawacki, & Philip O. Buck. (2005). The Effects of Past Sexual Assault Perpetration and Alcohol Consumption on Men's Reactions to Women's Mixed Signals. Journal of Social and Clinical Psychology. 24(2). 129–155. 48 indexed citations
19.
Abbey, Antonia, et al.. (2003). Sexual assault and alcohol consumption: what do we know about their relationship and what types of research are still needed?. Aggression and Violent Behavior. 9(3). 271–303. 348 indexed citations
20.
Abraham, Henry J., et al.. (1963). Other Activities. American Political Science Review. 57(1). 250–251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026